Growing Incidence Of Autoimmune Diseases Fuels Demand For Humira Drug: Pivotal Factor Influencing Humira Drug Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Humira Drug Market Size Growth Forecast: What to Expect by 2025?
The market size for the Humira drug has seen robust expansion in the past few years. It is projected to escalate from $9.74 billion in 2024 to $10.33 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.0%. Various factors contributing to this growth trajectory in the historic period include the advent of biologics, advancements in biotechnology, patient preferences for efficient therapies, and shifting tendencies in physician adoption and prescription.

How Will the Humira Drug Market Size Evolve and Grow by 2029?
The market for the drug Humira is anticipated to undergo robust expansion in the coming years. The market is projected to reach a value of "$13.93 billion in 2029, with a compound annual growth rate (CAGR) of 7.8%. This growth during the forecasted period can be ascribed to factors such as the advent of biosimilar market, modifications in healare policies, emphasis on cost-effectiveness, investment in research and development, precision treatments, and personalized medicine. Significant trends likely in this period include the generation of real-world evidence, increased usage in children, the move towards self-administration of medications, value-based pricing structures, and the development of targeted therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/humira-drug-global-market-report

What Drivers Are Propelling the Growth of Humira Drug Market Forward?
The escalation in the occurrence rate of autoimmune disorders is predicted to boost the humira drug market's progression in the future. Autoimmune disease is characterized as a condition in which the body's own immune system assaults and demolishes healthy tissues and cells. Humira drug is administered to alleviate pain and inflammation instigated by numerous autoimmune diseases, therefore, the increased occurrence rate of these diseases uplifts the demand for this drug. For example, in March 2024, the National Health Council, an American non-profit organization, informed that approximately 50 million American citizens are affected by autoimmune diseases. However, owing to the complications in diagnosing these diseases, this number is likely to be underestimated. The situation is further aggravated by the approaching autoimmunity epidemic, with some researches hinting towards an annual increment of 3-12%. Consequently, the rise in the occurrence rate of autoimmune disease will propel the HUMIRA drug market forward.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11934&type=smp

Which Emerging Trends Are Transforming the Humira Drug Market in 2025?
A key trend in the humira drug market is product innovations. To maintain their market position, leading companies in this field are producing new biologics and biosimilars. For instance, in April 2023, Biosimilar Hyrimoz (adalimumab), a citrate-free high-concentration formulation (HCF) was introduced by Swiss pharmaceutical company, Sandoz. This was approved by the European Commission. The adalimumab citrate-free HCF (100 mg/mL) formulation offers a 50% reduction in the injection volume, resulting in fewer injections required for patients who need a dosage of 80 mg/mL or more. This is relevant to a variety of diseases such as rheumatic diseases and Crohn's disease, which can benefit from an improved patient experience.

What Are the Key Segments in the Humira Drug Market?
The humira drug market covered in this report is segmented -

1) By Type: Humira Syringe, Humira Pen
2) By Application: Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn's Disease, Other Applications
3) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Humira Syringe: Pre-Filled Syringe, Disposable Syringe
2) By Humira Pen: Auto-Injector Pen, Pre-Filled Injection Pen

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11934&type=smp

Who Are the Key Players Shaping the Humira Drug Market's Competitive Landscape?
Major companies operating in the humira drug market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

What Geographic Markets Are Powering Growth in the Humira Drug Market?
North America was the largest region in the humira drug market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11934

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.